APA (7th ed.) Citation

H, P., S, F., K, X., J, L., X, X., M, W., . . . L, H. (2026). Targeting soluble PD-1 alleviates peritoneal fibrosis by modulating PD-L1 recycling and mesothelial-mesenchymal transition. Translational research : the journal of laboratory and clinical medicine, 296, 70. https://doi.org/10.1016/j.trsl.2026.07.005

Chicago Style (17th ed.) Citation

H, Peng, et al. "Targeting Soluble PD-1 Alleviates Peritoneal Fibrosis by Modulating PD-L1 Recycling and Mesothelial-mesenchymal Transition." Translational Research : The Journal of Laboratory and Clinical Medicine 296 (2026): 70. https://doi.org/10.1016/j.trsl.2026.07.005.

MLA (9th ed.) Citation

H, Peng, et al. "Targeting Soluble PD-1 Alleviates Peritoneal Fibrosis by Modulating PD-L1 Recycling and Mesothelial-mesenchymal Transition." Translational Research : The Journal of Laboratory and Clinical Medicine, vol. 296, 2026, p. 70, https://doi.org/10.1016/j.trsl.2026.07.005.